China NMPA Inspection - Yangling Biomedical Technology Co., Ltd. - July 09, 2018
China NMPA unannounced inspection for Yangling Biomedical Technology Co., Ltd. published July 09, 2018. An inspection by China's State Food and Drug Administration, with findings finalized by July 9, 2018, revealed severe compliance deficiencies at Yangl
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA unannounced inspection for Yangling Biomedical Technology Co., Ltd. published July 09, 2018. An inspection by China's State Food and Drug Administration, with findings finalized by July 9, 2018, revealed severe compliance deficiencies at Yangl
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Inspection Date
Unknown Date
Product Type
Drugs
ID: a9e5c08c-8c98-400d-9221-e68e403b491c
View on DashboardTransform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox